Your browser doesn't support javascript.
loading
A Novel Potent and Highly Specific Inhibitor against Influenza Viral N1-N9 Neuraminidases: Insight into Neuraminidase-Inhibitor Interactions.
Sriwilaijaroen, Nongluk; Magesh, Sadagopan; Imamura, Akihiro; Ando, Hiromune; Ishida, Hideharu; Sakai, Miho; Ishitsubo, Erika; Hori, Takanori; Moriya, Setsuko; Ishikawa, Takeshi; Kuwata, Kazuo; Odagiri, Takato; Tashiro, Masato; Hiramatsu, Hiroaki; Tsukamoto, Kenji; Miyagi, Taeko; Tokiwa, Hiroaki; Kiso, Makoto; Suzuki, Yasuo.
Afiliación
  • Sriwilaijaroen N; Department of Preclinical Sciences, Faculty of Medicine, Thammasat University , Pathumthani 12120, Thailand.
  • Magesh S; Health Science Hills, College of Life and Health Sciences, Chubu University , Aichi 487-8501, Japan.
  • Ishida H; Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University , Kyoto 606-8501, Japan.
  • Ishikawa T; Division of Cancer Glycosylation Research, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University , Sendai 981-8558, Japan.
  • Tashiro M; Influenza Virus Research Center, National Institute of Infectious Diseases , Tokyo 208-0011, Japan.
  • Hiramatsu H; Influenza Virus Research Center, National Institute of Infectious Diseases , Tokyo 208-0011, Japan.
  • Tsukamoto K; Health Science Hills, College of Life and Health Sciences, Chubu University , Aichi 487-8501, Japan.
  • Miyagi T; Research Team for Zoonotic Diseases, National Institute of Animal Health , Ibaraki 305-0856, Japan.
  • Tokiwa H; Division of Cancer Glycosylation Research, Institute of Molecular Biomembrane and Glycobiology, Tohoku Pharmaceutical University , Sendai 981-8558, Japan.
  • Suzuki Y; Institute for Integrated Cell-Material Sciences (WPI-iCeMS), Kyoto University , Kyoto 606-8501, Japan.
J Med Chem ; 59(10): 4563-77, 2016 05 26.
Article en En | MEDLINE | ID: mdl-27095056
ABSTRACT
People throughout the world continue to be at risk for death from influenza A virus, which is always creating a new variant. Here we present a new effective and specific anti-influenza viral neuraminidase (viNA) inhibitor, 9-cyclopropylcarbonylamino-4-guanidino-Neu5Ac2en (cPro-GUN). Like zanamivir, it is highly effective against N1-N9 avian and N1-N2 human viNAs, including H274Y oseltamivir-resistant N1 viNA, due to its C-6 portion still being anchored in the active site, different from the disruption of oseltamivir's C-6 anchoring by H274Y mutation. Unlike zanamivir, no sialidase inhibitory activity has been observed for cPro-GUN against huNeu1-huNeu4 enzymes. Broad efficacy of cPro-GUN against avian and human influenza viruses in cell cultures comparable to its sialidase inhibitory activities makes cPro-GUN ideal for further development for safe therapeutic or prophylactic use against both seasonal and pandemic influenza.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Orthomyxoviridae / Inhibidores Enzimáticos / Neuraminidasa Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Tailandia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antivirales / Orthomyxoviridae / Inhibidores Enzimáticos / Neuraminidasa Límite: Animals / Humans Idioma: En Revista: J Med Chem Asunto de la revista: QUIMICA Año: 2016 Tipo del documento: Article País de afiliación: Tailandia